Sign in
CompletedNo phase

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Key facts

Who runs it
University of Minnesota
Where
Boston, Camden, Chattanooga, Chicago, Columbus, Dayton, Detroit, Durham, Milwaukee, New York, Newark, Richmond, Rochester, San Diego, Springfield, The Bronx, and Washington D.C., United StatesSee the 18 sitesAlso in 11 other countries, 45 sites
Trial code
Status
Completed
People taking part
1,000 people, planned
Started
Aug 2009
Ended
30 Aug 2024
Type of study
Observational, 3 groups
Record updated
21 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Be ≥ 18 years of age
  • Have been admitted to hospital
  • Have a signed informed consent by participant or surrogate/representative
  • Have a local diagnosis (confirmed or suspected) of influenza, or of a targeted non-influenza viral respiratory infection*, resulting in (or extending a previous) hospitalization; A list of targeted non-influenza respiratory viruses is maintained on the INSIGHT website

Who cannot take part

  • Current imprisonment, or compulsory detention (involuntary incarceration) for treat of a psychiatric or physical illness

Where in United States

Also in 11 other countries, 45 sites

  • Brigham and Women's HospitalBoston, United States
  • Cooper University HospitalCamden, United States
  • University of Tennessee College of MedicineChattanooga, United States
  • University of Illinois at ChicagoChicago, United States
  • The Ohio State University Medical CenterColumbus, United States
  • Miami Valley HospitalDayton, United States
  • Henry Ford Health SystemDetroit, United States
  • Duke UniversityDurham, United States
  • Medical College of WisconsinMilwaukee, United States
  • Cornell ID-CRUNew York, United States
  • New Jersey Medical School Adult Clinical Research CenterNewark, United States
  • Virginia Commonwealth UniversityRichmond, United States
  • Mayo ClinicRochester, United States
  • UCSD Antiviral Research CenterSan Diego, United States
  • Baystate Infectious Diseases Clinical ResearchSpringfield, United States
  • Montefiore Medical CenterThe Bronx, United States
  • George Washington Medical Faculty AssociatesWashington D.C., United States
  • Washington DC VA Medical CenterWashington D.C., United States

About the trial

What the trial wants to find out

Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus, this observational study was initiated to estimate rates of morbidity and mortality and to examine predictors of severity among participants with 2009 H1N1 infection. In 2011, as surveillance indicated that 2009 H1N1 virus was co-circulating with other seasonal influenza A and B viruses worldwide, the protocol was expanded to include other influenza A subtypes and influenza B viruses. The current version of the protocol (released in August 2013) further broadens the scope of this observational study. With the recognition that novel respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public health importance, the objectives of this protocol have been expanded.

The 3 groups in the trial

  • Influenza

    Influenza A and subtypes such as H3N2 and 2009 H1N1 or influenza B

  • Novel Respiratory Virus-1

    MERS-CoV (Middle East Respiratory Syndrome Coronavirus

  • Novel Respiratory Virus-2

    SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses
Publications
Record updated
21 October 2024